Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04271917 · ClinicalTrials.gov registry record · Phase 3
Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients
A Phase 3 study, sponsored by University of Tennessee.
- Completed
- Registry status
- Phase 3
- Development phase
- 68
- Enrollment target
NCT04271917 is a Phase 3 study that has completed, run by University of Tennessee. The registered enrollment target is 68 participants.
The verdict
NCT04271917, a Phase 3 study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.
Interventions
- DRUG placebo
- DRUG cannabidiol
- DRUG acetaminophen 500mg and ibuprofen 200mg combo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2022-03-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04271917
The ClinicalTrials.gov registry entry for NCT04271917 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT04271917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04271917 about?
NCT04271917 is a clinical study titled "Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients". The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.
What is the current status of trial NCT04271917?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 68 participants. The study started on 2020-02-24. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04271917?
The interventions under investigation include: placebo (DRUG), cannabidiol (DRUG), acetaminophen 500mg and ibuprofen 200mg combo (DRUG).
Who is sponsoring clinical trial NCT04271917?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.